Physician profile
Willie Lu
NPI 1114959558
$2,475.21
in general payments reported to CMS, 2019-2025
13 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $580 · 2021: $625 · 2022: $55.93 · 2023: $66.28 · 2024: $303 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $681.26 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $601.63 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $466.90 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $283.33 | 2019-2021 | |
| Lilly USA, LLC | $174.91 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $81.78 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.76 | 2019 | |
| Amgen INC. | $37.50 | 2020 | |
| Astellas Pharma US INC | $33.63 | 2025 | Veozah |
| Janssen Biotech, INC. | $22.82 | 2019 | |
| Amarin Pharma, INC. | $18.56 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.